MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel bothin vitroandin vivo
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel bothin vitroandin vivo
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 16, Issue 2, Pages 261-267
Publisher
Informa UK Limited
Online
2015-10-22
DOI
10.1080/15384047.2014.1001287
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence
- (2016) Bernard S. Marasa et al. Aging-US
- MicroRNAs: master regulators of drug resistance, stemness, and metastasis
- (2014) Umar Raza et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1
- (2014) Jian Chen et al. TUMOR BIOLOGY
- Identification of new p53 target microRNAs by bioinformatics and functional analysis
- (2013) Alessandra Bisio et al. BMC CANCER
- miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer
- (2013) Y Shen et al. BRITISH JOURNAL OF CANCER
- Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin
- (2013) J Cai et al. Oncogenesis
- Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway
- (2012) Saurabh Singh et al. PLoS One
- miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers
- (2012) Liqin Du et al. PLoS One
- Is nasopharyngeal cancer really a "Cantonese cancer"?
- (2012) Joseph Tien Seng Wee et al. Chinese Journal of Cancer
- Up-regulation ofmiR-21Mediates Resistance to Trastuzumab Therapy for Breast Cancer
- (2011) Chang Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- p53-dependent Induction ofPVT1and miR-1204
- (2011) Anthony M. Barsotti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo
- (2011) A Holleman et al. ONCOGENE
- microRNA and Cancer
- (2010) Mengfeng Li et al. AAPS Journal
- Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression
- (2010) Xiaowei Peng et al. ANTI-CANCER DRUGS
- MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol
- (2010) Yu Ren et al. BMC CANCER
- MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression
- (2010) Yasunori Fujita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma
- (2009) Xia-Yun He et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma
- (2008) Swan Swan Leong et al. CANCER
- The Identification of MicroRNAs in a Genomically Unstable Region of Human Chromosome 8q24
- (2008) K. Huppi et al. MOLECULAR CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now